Open AccessNew indications for dabigatran: A suggestion from a drug use evaluation study
Author(s) -
Farzaneh Ashrafi,
Najmeh Rezaie,
Sarah Mousavi
Publication year - 2017
Publication title -
journal of research in pharmacy practice
Language(s) - English
Resource type - Journals
eISSN - 2319-9644
pISSN - 2279-042X
DOI - 10.4103/jrpp.jrpp_17_54
Subject(s) - dabigatran , medicine , dosing , warfarin , intensive care medicine , rivaroxaban , drug , atrial fibrillation , anesthesia , pharmacology
Dabigatran etexilate is a novel oral anticoagulant with several advantages over warfarin such as no need for routine monitoring and fewer drug interactions. This drug was added to our hospital's formulary in 2012. The objective of this study was to assess the rational drug use of dabigatran at a large teaching hospital.